Brief: Oncoarendi Therapeutics H1 Net Loss Widens To 1.9 Million Zlotys

Molecure SA

25/09/2018 16:24

Sept 25 (Reuters) - ONCOARENDI THERAPEUTICS SA  OAT.WA :
    * H1 NET LOSS 1.9 MILLION ZLOTYS VERSUS LOSS 0.8 MILLION
ZLOTYS
YEAR AGO
    * H1 OPERATING REVENUE 0.6 MILLION ZLOTYS VERSUS 0.5 MILLION
ZLOTYS YEAR AGO

Source text for Eikon:  ID:nEM1PM5jGa 
Further company coverage:  OAT.WA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))